A Phase 4 interventional study of Copper T 380A IUD in Contraception, sponsored by sara AbdAllah. Status unknown. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-27.
Sponsored by sara AbdAllah · Phase 4, Interventional, and Treatment
The study aims to compare immediate post-placental (within 10 minutes of placenta delivery) intrauterine contraceptive device (Copper T 380A) insertion versus conventional placement at 6 weeks (often referred to as delayed or interval insertion) regarding the clinical outcomes (safety, efficacy, expulsion and continuation rates) for women undergoing caesarean section.
After informed consent is obtained, eligible study participants will be randomized into 2 groups:
Group (A): 100 Women will receive the Pregna ® IUD at the 6 week postpartum visit Group (B): 100 Women will receive the Pregna ® IUD within 10 minutes of delivery of the placenta during caesarean section.
Insertion Technique:
During caesarean section:
Uterine cavity will be inspected for presence of malformations following placental delivery, which would limit use of IUCD.The IUCD (Pregna Copper T 380A) will be removed from the insertion sleeve and will be placed on the sterile field. Uterus is stabilized by grasping it at fundus. Insertion will be done during cesarean delivery, after ex pulsion of placenta and through the uterine incision, manually (IUCD is Held between middle and index finger). It will be inserted into the uterus through uterine incision and will be released at fundus of uterus. Hand will be removed slowly from the uterus. Enough care will be taken not to dislodge IUCD as hand is removed. Strings will be guided toward the lower uterine segment without disturbing IUCD'S fundal position. Enough Care will be taken not to include IUCD strings during uterine closure.
Delayed postpartum IUDs Will be inserted in the usual sterile fashion as described in the manufacturer's instructions at the 6-week postpartum visit
Later Prior to Discharge:
She will be informed about the IUCD side effects and normal postpartum symptoms.
Follow up visits:
The IUD will be removed in the case of partial expulsion, bleeding or pain, or at the patient's request.
Ethical Considerations
1-Approval by the institution ethical committee 2-Individual Consent Process: Written informed consent will be taken after explaining the study objective the procedures to potential participants. Participation will be voluntary and participants will be informed that the decision not to participate will not impact on the quality of care they receive.
Data will be statistically described in terms of mean + standard deviation (+/- SD), frequencies (number of cases) and relative frequencies (percentages) when appropriate. Comparison of numerical variables between the study groups will be done using Student t test for independent samples. For comparing categorical data, Chi square (X2) test will be performed. Exact test will be used instead when the expected frequency is less than 5. P values less than 0.05 will be considered statistically significant.
This is the only study on the registry with sara AbdAllah as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Subjects randomized to interval placement will have their Copper T 380A IUD placed in the office at six weeks postpartum or later
Device: Copper T 380A IUD
Subjects randomized to receive the Copper T 380A IUD within 10 minutes of delivery of the placenta during caesarean section.
Device: Copper T 380A IUD
intrauterine contraceptive device T-shaped loaded with cupper
Also known as: Pregna
Expulsion: Complete IUD expulsion will be verified clinically and by transvaginal ultrasound
Complete IUD expulsion will be verified clinically and by transvaginal ultrasound. An IUD will be considered to be partially expelled if a distance greater than 10 mm is measured between the vertical arm of the IUD and the junction between the endometrium and the uterine cavity)
Time frame: 6 months
Uterine perforation (assessed by pelvic ultrasonography or X-ray)
To be assessed by pelvic ultrasonography or X-ray pelvis will to note for misplaced IUD
Time frame: 6 months
Pelvic pain (using the 0-10 Numeric Pain Rating Scale)
Using the 0-10 Numeric Pain Rating Scale and analgesic doses required
Time frame: 6 months
Strings not visible (assessed by speculum examination)
To be assessed by speculum examination.
Time frame: 6 months
Pelvic infection: number of participants with Pelvic infection
number of participants with Pelvic infection
Time frame: 6 months
Psychological (satisfied or not) using questionnaire
using questionnaire
Time frame: 6 months
Pregnancy (assessed by serum pregnancy test and pelvic ultrasound)
To be assessed by serum pregnancy test and pelvic ultrasound in suspicious cases (missed period - misplaced IUD - expelled IUCD either partial or complete)
Time frame: 6 months
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.